Next Article in Journal
Comprehensive Assessment of Pharmacokinetics, Pharmacodynamics, and Tolerability of Ligelizumab in Healthy Volunteers and Patients with Chronic Spontaneous Urticaria to Optimize Its Subcutaneous Delivery System
Previous Article in Journal
A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice
 
 
Communication

Article Versions Notes

Pharmaceutics 2023, 15(9), 2265; https://doi.org/10.3390/pharmaceutics15092265
Action Date Notes Link
article xml file uploaded 1 September 2023 07:24 CEST Original file -
article xml uploaded. 1 September 2023 07:24 CEST Update https://www.mdpi.com/1999-4923/15/9/2265/xml
article pdf uploaded. 1 September 2023 07:24 CEST Version of Record https://www.mdpi.com/1999-4923/15/9/2265/pdf
article html file updated 1 September 2023 07:25 CEST Original file https://www.mdpi.com/1999-4923/15/9/2265/html
Back to TopTop